Companies at Berytech


MeaCor is developing a novel medical device that aims at treating without open heart surgery, a very serious heart condition that affects hundreds of thousands of patients in NA and the world: mitral valve regurgitation.

The start-up is a spinoff from Mcgill University and is currently in the product development phase with anticipated pre-clinical trials during the year 2016.